Hikma Pharma
Is this breakout a good trade for you?
Will Hikma turn, or will it continue to rise beyond 1875p?
- The chart shows price action for Hikma since August
- The shares have broken above resistance at 1845p
- Currently trading at 1870p (at time of writing).
- The ‘trend is your friend’. Will it continue?
- Shares -11.8% from 2018 highs; +126.4% from 2018 lows; +65.3% year-to-date.
- 27 Nov: Hikma announces injectable licensing agreement
- 19 Nov: Hikma launches Triazolam tablets
- Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
Trading Hikma– An Example
Let’s say the breakout appeals to you, you think it’s likely to continue. You decide to buy exposure to £10,000 worth of Hikma using a CFD, at the current price of 1870p. To do this, you need £2,000.
Let’s assume the Hikma trend continues to 2050p Aug highs (+9.6%). Your profit would be £960, from your initial investment of £2,000.
Conversely, let’s assume you open the above position, and place a stop-loss at 5% from the current price. Hikma breaks lower, falling 5% and it hits your stop-loss. Your loss would be £500.
This is provided for information purposes only. It should not be taken as a recommendation.